Literature DB >> 2749738

Extent of cutaneous metabolism during percutaneous absorption of xenobiotics.

R L Bronaugh1, R F Stewart, J E Storm.   

Abstract

In vitro percutaneous absorption studies generally do not determine whether biotransformation occurs during passage of a substance through the skin. Since it has recently been demonstrated that several chemicals are metabolized during skin permeation, we investigated the metabolism of five additional compounds (14C-labeled) after application to fuzzy rat skin: caffeine, p,p'-DDT, butylated hydroxytoluene (BHT), salicylic acid, and acetyl ethyl tetramethyltetralin (AETT). The viability of skin was maintained with a tissue culture medium. Radioactivity of each substrate and any metabolites in skin and receptor fluid was measured so that the absorption and metabolism of water-insoluble compounds would be accurately determined. Percutaneous absorption ranged from a low of 13% of the applied dose for BHT to a high of 49% for DDT. BHT was metabolized in skin to 4-hydroxy-BHT and an unknown metabolite. Of the absorbed radioisotope, 6.6% was isolated in biotransformed products found mainly in the receptor fluid. AETT was also metabolized during absorption, with 1.9% of the absorbed radioisotope found in two unknown peaks. Caffeine, DDT, and salicylic acid were not metabolized during skin permeation. Skin and liver microsomal metabolism was measured for all compounds except DDT. Metabolism in skin was observed only for the compounds also biotransformed in the diffusion cell; BHT and AETT were metabolized at 113 and 2.5 pmol/min/mg protein, respectively. In this study, as in others, skin metabolism was substantially less than the corresponding metabolism in liver. Therefore, a low rate of liver metabolism such as that found for caffeine, salicylic acid, and DDT might often be predictive of the absence of measurable metabolism during skin permeation. It seems likely that for many compounds, the biotransformations in skin will be small in terms of the percentage of absorbed material that is metabolized. Nevertheless, with potent compounds, even small quantities of a metabolite can be important and for pharmacokinetic studies, viability of skin must be maintained.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2749738     DOI: 10.1016/0041-008x(89)90160-9

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  11 in total

Review 1.  Xenobiotica-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; Robert Landsiedel
Journal:  Arch Toxicol       Date:  2018-06-18       Impact factor: 5.153

2.  Human cadaver skin viability for in vitro percutaneous absorption: storage and detrimental effects of heat-separation and freezing.

Authors:  R C Wester; J Christoffel; T Hartway; N Poblete; H I Maibach; J Forsell
Journal:  Pharm Res       Date:  1998-01       Impact factor: 4.200

3.  In vitro cutaneous metabolism of DDT in human and animal skins.

Authors:  D Moir; T M Marwood; R P Moody
Journal:  Bull Environ Contam Toxicol       Date:  1994-03       Impact factor: 2.151

Review 4.  Xenobiotic-metabolizing enzymes in the skin of rat, mouse, pig, guinea pig, man, and in human skin models.

Authors:  F Oesch; E Fabian; K Guth; R Landsiedel
Journal:  Arch Toxicol       Date:  2014-11-05       Impact factor: 5.153

5.  In vitro skin absorption and metabolism of benzoic acid, p-aminobenzoic acid, and benzocaine in the hairless guinea pig.

Authors:  D Nathan; A Sakr; J L Lichtin; R L Bronaugh
Journal:  Pharm Res       Date:  1990-11       Impact factor: 4.200

6.  In vitro cutaneous disposition of a topical diclofenac lotion in human skin: effect of a multi-dose regimen.

Authors:  P G Hewitt; N Poblete; R C Wester; H I Maibach; J Z Shainhouse
Journal:  Pharm Res       Date:  1998-07       Impact factor: 4.200

7.  Biochemical responses of skin to allergenic and non-allergenic nitrohalobenzenes. Evidence that an NADPH-dependent reductase in skin may act as a prohapten-activating enzyme.

Authors:  R J Schmidt; L Y Chung
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

8.  Irritantcy potential and sub acute dermal toxicity study of Pistacia lentiscus fatty oil as a topical traditional remedy.

Authors:  Zouhir Djerrou; Hdria Djaalab; Foulla Riachi; Mennouba Serakta; Aziez Chettoum; Zineb Maameri; Badaoui Boutobza; Youcef Hamdi-Pacha
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-04-12

Review 9.  Dermal exposure to environmental contaminants in the Great Lakes.

Authors:  R P Moody; I Chu
Journal:  Environ Health Perspect       Date:  1995-12       Impact factor: 9.031

10.  Comparison of the metabolism of 10 chemicals in human and pig skin explants.

Authors:  C Géniès; E L Jamin; L Debrauwer; D Zalko; E N Person; J Eilstein; S Grégoire; A Schepky; D Lange; C Ellison; A Roe; S Salhi; R Cubberley; N J Hewitt; H Rothe; M Klaric; H Duplan; C Jacques-Jamin
Journal:  J Appl Toxicol       Date:  2018-10-21       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.